Does antiretroviral-induced hyperlipidaemia constitute a cardiovascular risk?
Gilleece
Y
Y
Chelsea and Westminster Hospital, London SW10 9NH, UK.
Nelson
M
M
D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology*; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced* / Q000150:complications; D015994:Incidence; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects; D012307:Risk Factors; D017211:Treatment Failure
D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors